Avaii Wealth Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $949K | Sell |
26,373
-2,927
| -10% | -$105K | 0.42% | 31 |
|
|
2025
Q1 | $1.16M | Sell |
29,300
-1,093
| -4% | -$43.1K | 0.62% | 24 |
|
|
2024
Q4 | $915K | Buy |
30,393
+1,409
| +5% | +$42.4K | 0.45% | 30 |
|
|
2024
Q3 | $678K | Sell |
28,984
-1,249
| -4% | -$29.2K | 0.34% | 43 |
|
|
2024
Q2 | $538K | Buy |
30,233
+342
| +1% | +$6.08K | 0.3% | 59 |
|
|
2024
Q1 | $455K | Buy |
29,891
+608
| +2% | +$9.25K | 0.27% | 70 |
|
|
2023
Q4 | $500K | Sell |
29,283
-4,739
| -14% | -$80.9K | 0.33% | 68 |
|
|
2023
Q3 | $284K | Buy |
34,022
+15,468
| +83% | +$129K | 0.22% | 101 |
|
|
2023
Q2 | $461K | Sell |
18,554
-240
| -1% | -$5.96K | 0.35% | 66 |
|
|
2023
Q1 | $283K | Buy |
18,794
+1,934
| +11% | +$29.1K | 0.25% | 96 |
|
|
2022
Q4 | $199K | Buy |
16,860
+2,943
| +21% | +$34.8K | 0.18% | 120 |
|
|
2022
Q3 | $82K | Buy |
+13,917
| New | +$82K | 0.09% | 108 |
|
|
2022
Q2 | – | Sell |
-17,554
| Closed | -$167K | – | 120 |
|
|
2022
Q1 | $167K | Buy |
+17,554
| New | +$167K | 0.15% | 108 |
|